Comparing two ways to deliver a pain self-management program for chronic pain
Optimization of a Chronic Pain Self-management Program - a Pilot Randomized Clinical Trial
This study is testing two different ways to deliver a 10-week online pain management program for adults with chronic musculoskeletal pain to see which method helps them feel better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 86 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Laval University Academic / other |
| Locations | 1 site (Québec) |
| Trial ID | NCT06174246 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of two different delivery methods for a 10-week online self-management program designed for individuals with chronic musculoskeletal pain. Participants will be divided into two groups: one receiving the program independently and the other receiving additional support through physiotherapist-led sessions and group interactions. The study will assess the impact of these interventions on pain-related disability, pain intensity, and psychological factors over a period of 26 weeks. The trial will involve 86 adults aged 18 to 75, recruited from pain-management program waiting lists and social media.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 75 with chronic musculoskeletal pain lasting more than three months.
Not a fit: Patients with rheumatoid, inflammatory or neurodegenerative diseases, fibromyalgia, or complex regional pain syndrome may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve pain management and quality of life for patients with chronic musculoskeletal pain.
How similar studies have performed: Previous studies have shown that self-management programs can be effective for chronic pain, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Having musculoskeletal pain for more than 3 months. Exclusion Criteria: * Unable to participate throughout the 26 weeks of the study. * Having a diagnosis of rheumatoid, inflammatory or neurodegenerative diseases, fibromyalgia or of complex regional pain syndrome. * Having received a corticosteroid injection in the previous twelve weeks.
Where this trial is running
Québec
- Cirris (Centre interdisciplinaire de recherche en réadaptation et intégration sociale) — Québec, Canada (Recruiting)
Study contacts
- Principal investigator: Jean-Sébastien Roy, PhD — Laval University
- Study coordinator: Jean-Sébastien Roy, PhD
- Email: jean-sebastien.roy@fmed.ulaval.ca
- Phone: 418-529-9141
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.